Journal
Cancers (Basel)
Publication Date
6-14-2022
Volume
14
Issue
12
First Page
2932
Document Type
Open Access Publication
DOI
10.3390/cancers14122932
Rights and Permissions
Jaswal, S.; Sanders, V.; Pullarkat, P.; Teja, S.; Salter, A.; Watkins, M.P.; Atagu, N.; Ludwig, D.R.; Mhlanga, J.; Mellnick, V.M.; Peterson, L.R.; Bartlett, N.L.; Kahl, B.S.; Fehniger, T.A.; Ghobadi, A.; Cashen, A.F.; Mehta-Shah, N.; Ippolito, J.E. Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Cancers 2022, 14, 2932. https://doi.org/10.3390/cancers14122932 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Jaswal, Shama; Sanders, Vanessa; Pullarkat, Priyanka; Teja, Stephanie; Salter, Amber; Watkins, Marcus P; Atagu, Norman; Ludwig, Daniel R; Mhlanga, Joyce; Mellnick, Vincent M; Peterson, Linda R; Bartlett, Nancy L; Kahl, Brad S; Fehniger, Todd A; Ghobadi, Armin; Cashen, Amanda F; Mehta-Shah, Neha; and Ippolito, Joseph E, "Metabolic biomarkers assessed with PET/CT predict sex-specific longitudinal outcomes in patients with diffuse large B-cell lymphoma." Cancers (Basel). 14, 12. 2932 (2022).
https://digitalcommons.wustl.edu/oa_4/78
